Optimal therapy for infections with carbapenem resistant GNB is not well established due to the weakness of data. Patients presenting with bloodstream infections caused by multidrug resistant Klebsiella pneumoniae were treated with a combination treatment. Optimal therapy for infections with carbapenem resistant Gram-negative bacteria is a serious problem in pediatric patients. We presented three cases who were successfully treated with addition of ertapenem to the combination treatment for bacteremia with multidrug resistant Klebsiella pneumoniae. Dual carbapenem treatment approach is a new approach for these infections and requires more data in children.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vInyP8
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract: Patients with neurofibromatosis type 1 (NF-1) have a well-known predisposition for certain types of malignancies, including lympho...
-
Astrophel' is a fanciful half-Greek anagram for the poet's own name, and Stella (Star) designates Lady Penelope Devereux, who at abo...
-
The global average temperature in 2016 was 1.1°C higher than pre-industrial levels and about 0.07°C higher than the previous record set in ...
-
Publication date: Available online 16 May 2017 Source: Experimental Cell Research Author(s): Katrin Ruisu, Riho Meier, Keiu Kask, Tambet T...
-
Oxford Textbook of Vascular Surgery . ThompsonM. M., FitridgeR., BoyleJ., ThompsonM., BrohiK., HinchliffeR. J., CheshireN., NaylorA. R., Lof...
-
Objective. Human umbilical cord mesenchymal stem cells (hUC-MSCs) potentially differentiate to various types of cells including neuron-like ...
-
Publication date: Available online 6 June 2017 Source: Biochimie Author(s): M.J. González-Fernández, R.P. Ramos-Bueno, I. Rodríguez-García...
-
The impact of industrialised societies on Earth has been described in a mathematical formula that should scare us all, says Owen Gaffney ...
-
Bumblebees have shown they can learn how to push a ball into a hole to get a reward, staking their claim to be considered tool users from ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου